- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-6269
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Circulating Tumour DNA in Melanoma—Clinic Ready? ; volume:24 ; number:3 ; day:8 ; month:2 ; year:2022 ; pages:363-373 ; date:3.2022
Current oncology reports ; 24, Heft 3 (8.2.2022), 363-373, 3.2022
- Urheber
-
Tivey, Ann
Britton, Fiona
Scott, Julie-Ann
Rothwell, Dominic
Lorigan, Paul
Lee, Rebecca
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11912-021-01151-6
- URN
-
urn:nbn:de:101:1-2022052906125857786796
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tivey, Ann
- Britton, Fiona
- Scott, Julie-Ann
- Rothwell, Dominic
- Lorigan, Paul
- Lee, Rebecca
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients
Detection of metastases using circulating tumour DNA in uveal melanoma
Bowel cancer chemoprevention - ready for the clinic?
Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy
Biomarkers in cancer/Circulating tumour markers
Circulating tumour DNA (ctDNA) as a biomarker in metachronous melanoma and colorectal cancer- a case report
Tumour-associated lymphangiogenesis in conjunctival malignant melanoma
Impact of Circulating and Tissue Biomarkers in Adjuvant and Neoadjuvant Therapy for High-Risk Melanoma: Ready for Prime Time?
Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
Ex vivo expansion of circulating tumour cells (CTCs)
Unravelling mutational signatures with plasma circulating tumour DNA
Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients
Detection of metastases using circulating tumour DNA in uveal melanoma
Bowel cancer chemoprevention - ready for the clinic?
Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy
Biomarkers in cancer/Circulating tumour markers
Circulating tumour DNA (ctDNA) as a biomarker in metachronous melanoma and colorectal cancer- a case report
Tumour-associated lymphangiogenesis in conjunctival malignant melanoma
Impact of Circulating and Tissue Biomarkers in Adjuvant and Neoadjuvant Therapy for High-Risk Melanoma: Ready for Prime Time?
Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
Ex vivo expansion of circulating tumour cells (CTCs)
Unravelling mutational signatures with plasma circulating tumour DNA
Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients
Detection of metastases using circulating tumour DNA in uveal melanoma
Bowel cancer chemoprevention - ready for the clinic?
Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy
Biomarkers in cancer/Circulating tumour markers
Circulating tumour DNA (ctDNA) as a biomarker in metachronous melanoma and colorectal cancer- a case report
Tumour-associated lymphangiogenesis in conjunctival malignant melanoma
Impact of Circulating and Tissue Biomarkers in Adjuvant and Neoadjuvant Therapy for High-Risk Melanoma: Ready for Prime Time?
Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
Ex vivo expansion of circulating tumour cells (CTCs)
Unravelling mutational signatures with plasma circulating tumour DNA